{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:58:47Z","timestamp":1782208727914,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002669","name":"Elekta AB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011676","name":"Elekta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.radonc.2023.109769","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T02:58:48Z","timestamp":1687921128000},"page":"109769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The impact of local control on widespread progression and survival in oligometastasis-directed SBRT: Results from a large international database"],"prefix":"10.1016","volume":"186","author":[{"given":"Yilin","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darby","family":"Erler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Badellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tithi","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roi","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Foote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin J.","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109769_b0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamaoncol.2021.7037","article-title":"Measuring the effect of local control from radiotherapy in patients with pancreatic adenocarcinoma","volume":"8","author":"Sanford","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.109769_b0010","doi-asserted-by":"crossref","unstructured":"Punglia RS, Morrow M, Winer EP, Harris JR, School HM. \u201cLocal Therapy and Survival in Breast Cancer,\u201d https:\/\/doi.org\/10.1056\/NEJMra065241 Jun. 2007; 356:2399\u20132405, doi: 10.1056\/NEJMRA065241.","DOI":"10.1056\/NEJMra065241"},{"key":"10.1016\/j.radonc.2023.109769_b0015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/JTO.0b013e3182429682","article-title":"Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma","volume":"7","author":"MacHtay","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109769_b0020","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2023.109769_b0025","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. Maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109769_b0030","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: The ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.109769_b0035","doi-asserted-by":"crossref","first-page":"e2026312","DOI":"10.1001\/jamanetworkopen.2020.26312","article-title":"Evaluation of definitive stereotactic body radiotherapy and outcomes in adults with extracranial oligometastasis","volume":"3","author":"Poon","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.radonc.2023.109769_b0040","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1634\/theoncologist.2012-0293","article-title":"The NOMS framework: Approach to the treatment of spinal metastatic tumors","volume":"18","author":"Laufer","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.radonc.2023.109769_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109769_b0050","doi-asserted-by":"crossref","unstructured":"Yamamoto T, et al. \u201cAnalyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival,\u201d BMC Cancer 2020; 20, doi: 10.1186\/s12885-020-07514-9.","DOI":"10.1186\/s12885-020-07514-9"},{"key":"10.1016\/j.radonc.2023.109769_b0055","doi-asserted-by":"crossref","unstructured":"Klement RJ, et al. \u201cThe impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: A combined analysis of 388 patients with 500 metastases,\u201d BMC Cancer 2019; 19, doi: 10.1186\/s12885-019-5362-5.","DOI":"10.1186\/s12885-019-5362-5"},{"key":"10.1016\/j.radonc.2023.109769_b0060","doi-asserted-by":"crossref","unstructured":"Salama JK, et al. \u201cStereotactic body radiotherapy for multisite extracranial oligometastases: Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease,\u201d Cancer 2012; 118, doi: 10.1002\/cncr.26611.","DOI":"10.1002\/cncr.26611"},{"key":"10.1016\/j.radonc.2023.109769_b0065","doi-asserted-by":"crossref","unstructured":"Zelefsky MJ, et al. \u201cPhase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer,\u201d International Journal of Radiation Oncology Biology Physics 2021; 110, doi: 10.1016\/j.ijrobp.2021.01.004.","DOI":"10.1016\/j.ijrobp.2021.01.004"},{"key":"10.1016\/j.radonc.2023.109769_b0070","doi-asserted-by":"crossref","unstructured":"Biswas T, Spratt DE. \u201cDose Escalation for Oligometastatic Disease: Is More Better?\u201d, International Journal of Radiation Oncology Biology Physics 2021; 110. doi: 10.1016\/j.ijrobp.2021.02.031.","DOI":"10.1016\/j.ijrobp.2021.02.031"},{"key":"10.1016\/j.radonc.2023.109769_b0075","article-title":"Local control and radionecrosis of brain metastases from non\u2013 small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors","author":"Leyrat","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109769_b0080","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ijrobp.2015.03.037","article-title":"Outcomes for spine stereotactic body radiation therapy and an analysis of predictors of local recurrence","volume":"92","author":"Bishop","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109769_b0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"van Leeuwen","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109769_b0090","doi-asserted-by":"crossref","unstructured":"Redmond KJ, et al. \u201cStereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines,\u201d International Journal of Radiation Oncology*Biology*Physics Sep. 2021; 111:68\u201380, doi: 10.1016\/j.ijrobp.2021.04.016.","DOI":"10.1016\/j.ijrobp.2021.04.016"},{"key":"10.1016\/j.radonc.2023.109769_b0095","doi-asserted-by":"crossref","unstructured":"Redmond KJ, et al. \u201cTumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases,\u201d International Journal of Radiation Oncology*Biology*Physics May 2021; 110:53\u201367, doi: 10.1016\/j.ijrobp.2020.10.034.","DOI":"10.1016\/j.ijrobp.2020.10.034"},{"key":"10.1016\/j.radonc.2023.109769_b0100","unstructured":"Milano MT, et al. \u201cThe Art of Radiotherapy: The Necessary Risk of Radiation Necrosis for Durable Control of Brain Metastases,\u201d International Journal of Radiation Oncology*Biology*Physics, no. Preprint."},{"key":"10.1016\/j.radonc.2023.109769_b0105","doi-asserted-by":"crossref","unstructured":"Kirkpatrick JP, Brenner DJ, Orton CG. \u201cThe linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery,\u201d Medical Physics 2009; 36. doi: 10.1118\/1.3157095.","DOI":"10.1118\/1.3157095"},{"key":"10.1016\/j.radonc.2023.109769_b0110","doi-asserted-by":"crossref","unstructured":"Brenner DJ. \u201cThe Linear-Quadratic Model Is an Appropriate Methodology for Determining Isoeffective Doses at Large Doses Per Fraction,\u201d Seminars in Radiation Oncology 2008; 18, doi: 10.1016\/j.semradonc.2008.04.004.","DOI":"10.1016\/j.semradonc.2008.04.004"},{"key":"10.1016\/j.radonc.2023.109769_b0115","doi-asserted-by":"crossref","unstructured":"Courdi A. \u201cHigh doses per fraction and the linear-quadratic model,\u201d Radiotherapy and Oncology 2010; 94. doi: 10.1016\/j.radonc.2009.08.019.","DOI":"10.1016\/j.radonc.2009.08.019"},{"key":"10.1016\/j.radonc.2023.109769_b0120","doi-asserted-by":"crossref","unstructured":"Otsuka S, et al. \u201cCompatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor,\u201d International Journal of Radiation Oncology Biology Physics 2011; 81, doi: 10.1016\/j.ijrobp.2011.05.034.","DOI":"10.1016\/j.ijrobp.2011.05.034"},{"key":"10.1016\/j.radonc.2023.109769_b0125","doi-asserted-by":"crossref","unstructured":"Redmond KJ, et al. \u201cA multinational report of technical factors on stereotactic body radiotherapy for oligometastases,\u201d http:\/\/dx.doi.org\/10.2217\/fon-2016-0479 Feb. 2017; 13:1081\u20131089, doi: 10.2217\/FON-2016-0479.","DOI":"10.2217\/fon-2016-0479"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023003079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023003079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:28:07Z","timestamp":1759123687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023003079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":25,"alternative-id":["S0167814023003079"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109769","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of local control on widespread progression and survival in oligometastasis-directed SBRT: Results from a large international database","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109769"}}